THE US FDA has approved a test
designed to detect antibodies to
viruses in donors of human blood
and blood components that are
associated with several diseases,
including some forms of leukemia
and neurologic diseases, Avioq
HTLV-I/II Microelisa System.
Additionally, the test is approved
for use as an aid in the diagnosis of
HTLV-I or HTLV-II infection and
related diseases.The above article was sent to subscribers in Pharmacy Daily's issue from 28 Mar 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Mar 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.